OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 - PubMed (original) (raw)
M Votruba, U E Pesch, D L Thiselton, S Mayer, A Moore, M Rodriguez, U Kellner, B Leo-Kottler, G Auburger, S S Bhattacharya, B Wissinger
Affiliations
- PMID: 11017080
- DOI: 10.1038/79944
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28
C Alexander et al. Nat Genet. 2000 Oct.
Abstract
Autosomal dominant optic atrophy (ADOA) is the most prevalent hereditary optic neuropathy resulting in progressive loss of visual acuity, centrocoecal scotoma and bilateral temporal atrophy of the optic nerve with an onset within the first two decades of life. The predominant locus for this disorder (OPA1; MIM 165500) has been mapped to a 1.4-cM interval on chromosome 3q28-q29 flanked by markers D3S3669 and D3S3562 (ref. 3). We established a PAC contig covering the entire OPA1 candidate region of approximately 1 Mb and a sequence skimming approach allowed us to identify a gene encoding a polypeptide of 960 amino acids with homology to dynamin-related GTPases. The gene comprises 28 coding exons and spans more than 40 kb of genomic sequence. Upon sequence analysis, we identified mutations in seven independent families with ADOA. The mutations include missense and nonsense alterations, deletions and insertions, which all segregate with the disease in these families. Because most mutations probably represent null alleles, dominant inheritance of the disease may result from haploinsufficiency of OPA1. OPA1 is widely expressed and is most abundant in the retina. The presence of consensus signal peptide sequences suggests that the product of the gene OPA1 is targeted to mitochondria and may exert its function in mitochondrial biogenesis and stabilization of mitochondrial membrane integrity.
Similar articles
- Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. Delettre C, et al. Nat Genet. 2000 Oct;26(2):207-10. doi: 10.1038/79936. Nat Genet. 2000. PMID: 11017079 - Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
Baris O, Delettre C, Amati-Bonneau P, Surget MO, Charlin JF, Catier A, Derieux L, Guyomard JL, Dollfus H, Jonveaux P, Ayuso C, Maumenee I, Lorenz B, Mohammed S, Tourmen Y, Bonneau D, Malthièry Y, Hamel C, Reynier P. Baris O, et al. Hum Mutat. 2003 Jun;21(6):656. doi: 10.1002/humu.9152. Hum Mutat. 2003. PMID: 14961560 - Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
Dadgar S, Hagens O, Dadgar SR, Haghighi EN, Schimpf S, Wissinger B, Garshasbi M. Dadgar S, et al. Exp Eye Res. 2006 Sep;83(3):702-6. doi: 10.1016/j.exer.2006.03.004. Epub 2006 May 12. Exp Eye Res. 2006. PMID: 16698014 - OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. Delettre C, et al. Mol Genet Metab. 2002 Feb;75(2):97-107. doi: 10.1006/mgme.2001.3278. Mol Genet Metab. 2002. PMID: 11855928 Review. - OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferré M, Guillet V, Gueguen N, Loiseau D, de Crescenzo MA, Verny C, Procaccio V, Lenaers G, Reynier P. Amati-Bonneau P, et al. Int J Biochem Cell Biol. 2009 Oct;41(10):1855-65. doi: 10.1016/j.biocel.2009.04.012. Epub 2009 Apr 21. Int J Biochem Cell Biol. 2009. PMID: 19389487 Review.
Cited by
- Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis.
Lopriore P, Palermo G, Meli A, Bellini G, Benevento E, Montano V, Siciliano G, Mancuso M, Ceravolo R. Lopriore P, et al. Mov Disord Clin Pract. 2024 Aug;11(8):948-965. doi: 10.1002/mdc3.14148. Epub 2024 Jun 28. Mov Disord Clin Pract. 2024. PMID: 38943319 Review. - Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess.
Galloway CA, Yoon Y. Galloway CA, et al. J Gen Physiol. 2012 Jun;139(6):455-63. doi: 10.1085/jgp.201210771. J Gen Physiol. 2012. PMID: 22641640 Free PMC article. No abstract available. - Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening.
Kumari S, Mehta SL, Milledge GZ, Huang X, Li H, Li PA. Kumari S, et al. Int J Biol Sci. 2016 Apr 27;12(6):688-700. doi: 10.7150/ijbs.13589. eCollection 2016. Int J Biol Sci. 2016. PMID: 27194946 Free PMC article. - The emerging roles of prohibitins in folliculogenesis.
Chowdhury I, Garcia-Barrio M, Harp D, Thomas K, Matthews R, Thompson WE. Chowdhury I, et al. Front Biosci (Elite Ed). 2012 Jan 1;4(2):690-9. doi: 10.2741/e410. Front Biosci (Elite Ed). 2012. PMID: 22201905 Free PMC article. Review. - OPA1 drives macrophage metabolism and functional commitment via p65 signaling.
Sánchez-Rodríguez R, Tezze C, Agnellini AHR, Angioni R, Venegas FC, Cioccarelli C, Munari F, Bertoldi N, Canton M, Desbats MA, Salviati L, Gissi R, Castegna A, Soriano ME, Sandri M, Scorrano L, Viola A, Molon B. Sánchez-Rodríguez R, et al. Cell Death Differ. 2023 Mar;30(3):742-752. doi: 10.1038/s41418-022-01076-y. Epub 2022 Oct 28. Cell Death Differ. 2023. PMID: 36307526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous